Kate Therapeutics
Caroline Dang is a Research Associate II at Kate Therapeutics with previous experience in research and development at Hologic, Inc. and BioLegend. Caroline also has a background in conservation work, served as Vice President of the Physical Therapy Club, and held various leadership roles in organizations promoting scientific importance and youth development. Caroline has a Bachelor's degree in Biology from the University of California, Riverside and is currently studying abroad at Maastricht University.
Kate Therapeutics
Kate Therapeutics (KateTx) is a patient-focused biotechnology company developing adeno-associated virus (AAV)-based gene therapies to treat genetically defined muscle and heart diseases. The company is applying novel technology platforms that directly address the key limitations of current gene therapies, including tissue-specific delivery and gene regulation. These breakthroughs have the potential to improve the efficacy and safety of gene therapies and enable the pursuit of a broader set of targets that are otherwise difficult to drug with current technologies.